Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib PK and Safety in Patients with Hepatic Impairment
NCT03359850Phase 1Completed
- Start
- Feb 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of niraparib in solid tumor (advanced stage) (2 arms). Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration, Area Under the Plasma Concentration-time Curve From Time 0 Extrapolated to Infinity and 4 more. Started Feb 2018; status: completed.
02
Drugs
niraparib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03359850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359850.